Doctors test 'Stop-and-Go' drug strategy to control tough leukemia
NCT ID NCT05478512
Summary
This study is testing a personalized treatment plan for young adults with a hard-to-treat form of chronic lymphocytic leukemia (CLL). All participants start with a two-drug combination. Doctors then check for tiny amounts of leftover cancer cells and adjust the treatment plan. Some patients stop treatment early if the cancer is undetectable, while others continue with a different drug combination to try to control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ematologia AO di Perugia
Perugia, Italy
-
Ematologia AOU Careggi
Florence, Italy
-
Ematologia AOUS - Policlinico S. M. alle Scotte
Siena, Italy
-
Ematologia IRST D.Amadori
Meldola, Italy
-
Ematologia Ospedale Infermi
Rimini, Italy
-
Ematologia Ospedale S.M. delle Croci
Ravenna, Italy
-
Ematologia Policlinico Gemelli
Roma, Italy
-
Ematologia Policlinico Umberto I
Roma, Italy
Conditions
Explore the condition pages connected to this study.